Representatives from CME Group gave a presentation and answered questions about the new CME disruptive practices rule. Speakers included Thomas LaSala, Managing Director & Chief Regulatory Officer, CME Group; Steve Schwartz, Executive Director, Global Head of Enforcement, CME Group; and Andrew Vrabel, Executive Director, Global Head of Investigations, CME Group.
